United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

atnahs pharma uk ltd - olsalazine sodium - oral tablet - 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - olsalazine sodium - oral tablet - 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - olsalazine sodium - oral tablet - 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - olsalazine sodium - oral tablet - 500mg

New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - olsalazine sodium 250mg - capsule - 250 mg - active: olsalazine sodium 250mg excipient: gelatin magnesium stearate opacode black s-1-17822 opacode black s-1-17823 - maintenance of patients with ulcerative colitis in remission. treatment of acute ulcerative colitis of mild to moderate severity with or without the concomitant use of steroids.

New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - olsalazine sodium 500mg (plus overage 1.2%) - tablet - 500 mg - active: olsalazine sodium 500mg (plus overage 1.2%) excipient: colloidal silicon dioxide crospovidone magnesium stearate povidone

United States - English - NLM (National Library of Medicine)

rebel distributors corp - warfarin sodium (unii: 6153cwm0cl) (warfarin - unii:5q7zvv76ei) - warfarin sodium 1 mg - warfarin sodium tablets are indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonary embolism. warfarin sodium tablets are indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. warfarin sodium tablets are indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction. anticoagulation is contraindicated in any localized or general physical condition or personal circumstance in which the hazard of hemorrhage might be greater than the potential clinical benefits of anticoagulation, such as: warfarin sodium tablets are contraindicated in women who are or may become pregnant because the drug passes through the placental barrier and may cause fatal hemorrhage to the fetus in utero. furthermore, there have been reports of birth malformations in children born to mothers who

Ireland - English - HPRA (Health Products Regulatory Authority)

atnahs pharma netherlands b.v. - olsalazine sodium - capsule, hard - 250 milligram(s) - aminosalicylic acid and similar agents; olsalazine

Ireland - English - HPRA (Health Products Regulatory Authority)

atnahs pharma netherlands b.v. - olsalazine sodium - tablet - 500 milligram(s) - aminosalicylic acid and similar agents; olsalazine

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - olsalazine sodium - oral suspension - 50mg/1ml